AAAAAA

   
Results: 1-23 |
Results: 23
SMALL-CELL LUNG-CANCER - A PERSPECTIVE ON THE PAST AND A PREVIEW OF THE FUTURE
Authors: COMIS RL FRIEDLAND DM GOOD BC
Citation: Rl. Comis et al., SMALL-CELL LUNG-CANCER - A PERSPECTIVE ON THE PAST AND A PREVIEW OF THE FUTURE, Oncology, 12(1), 1998, pp. 44-50
DEVELOPING AN AHC-MCO ALLIANCE FOR RESEARCH AND CARE
Authors: MYERS RE SCHLACKMAN N KALUZNY AD MURRAY J HANCHAK N NASH DB COMIS RL
Citation: Re. Myers et al., DEVELOPING AN AHC-MCO ALLIANCE FOR RESEARCH AND CARE, Health care management review, 23(1), 1998, pp. 64-69
THE COOPERATIVE GROUPS - PAST AND FUTURE
Authors: COMIS RL
Citation: Rl. Comis, THE COOPERATIVE GROUPS - PAST AND FUTURE, Cancer chemotherapy and pharmacology, 42, 1998, pp. 85-87
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
MOLECULAR ALTERATIONS TO HUMAN-CHROMOSOME 3P LOCI IN NEUROENDOCRINE LUNG-TUMORS
Authors: KOVATICH A FRIEDLAND DM DRUCK T HADACZEK P HUEBNER K COMIS RL HAUCK W MCCUE PA
Citation: A. Kovatich et al., MOLECULAR ALTERATIONS TO HUMAN-CHROMOSOME 3P LOCI IN NEUROENDOCRINE LUNG-TUMORS, Cancer, 83(6), 1998, pp. 1109-1117
THE IMPLEMENTATION OF TELEMEDICINE WITHIN A COMMUNITY CANCER NETWORK
Authors: LONDON JW MORTON DE MARINUCCI D CATALANO R COMIS RL
Citation: Jw. London et al., THE IMPLEMENTATION OF TELEMEDICINE WITHIN A COMMUNITY CANCER NETWORK, Journal of the American Medical Informatics Association, 4(1), 1997, pp. 18-24
PHASE-I TRIAL OF BUTHIONINE SULFOXIMINE IN COMBINATION WITH MELPHALANIN PATIENTS WITH CANCER
Authors: ODWYER PJ HAMILTON TC LACRETA FP GALLO JM KILPATRICK D HALBHERR T BRENNAN J BOOKMAN MA HOFFMAN J YOUNG RC COMIS RL OZOLS RF
Citation: Pj. Odwyer et al., PHASE-I TRIAL OF BUTHIONINE SULFOXIMINE IN COMBINATION WITH MELPHALANIN PATIENTS WITH CANCER, Journal of clinical oncology, 14(1), 1996, pp. 249-256
DISCUSSION - LUNG-CANCER
Authors: CARNEY DN BUNN PA BELANI CP",GIACCONE,"SHEPHERD FA CALVERT AH COMIS RL SPLINTER TAW ETTINGER DS JOHNSON DH LANGER CJ GRECO FA HAINSWORTH JD BONOMI P CURRAN WJ CHOY H GLANTZ MJ
Citation: Dn. Carney et al., DISCUSSION - LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 140-147
PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED RECOMBINANT TUMOR-NECROSIS-FACTOR AND RECOMBINANT INTERLEUKIN-2
Authors: KRIGEL RL PADAVICSHALLER K TOOMEY C COMIS RL WEINER LM
Citation: Rl. Krigel et al., PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED RECOMBINANT TUMOR-NECROSIS-FACTOR AND RECOMBINANT INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 17(3), 1995, pp. 161-170
PHASE-II EVALUATION OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN (M-VAC) IN ADVANCED, MEASURABLE BREAST-CARCINOMA
Authors: LANGER CJ CATALANO R WEINER LM SCHER R BAGCHI P SAREN B COMIS RL
Citation: Cj. Langer et al., PHASE-II EVALUATION OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN (M-VAC) IN ADVANCED, MEASURABLE BREAST-CARCINOMA, Cancer investigation, 13(2), 1995, pp. 150-159
PACLITAXEL AND CARBOPLATIN IN COMBINATION IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II TOXICITY, RESPONSE, AND SURVIVAL ANALYSIS
Authors: LANGER CJ LEIGHTON JC COMIS RL ODWYER PJ MCALEER CA BONJO CA ENGSTROM PF LITWIN S OZOLS RF
Citation: Cj. Langer et al., PACLITAXEL AND CARBOPLATIN IN COMBINATION IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II TOXICITY, RESPONSE, AND SURVIVAL ANALYSIS, Journal of clinical oncology, 13(8), 1995, pp. 1860-1870
PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ORAL ETOPOSIDE CHEMOTHERAPY FOR EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PILOT-STUDY
Authors: WOLFF AC ETTINGER DS NEUBERG D COMIS RL RUCKDESCHEL JC BONOMI PD JOHNSON DH
Citation: Ac. Wolff et al., PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ORAL ETOPOSIDE CHEMOTHERAPY FOR EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PILOT-STUDY, Journal of clinical oncology, 13(7), 1995, pp. 1615-1622
NEW CHEMOTHERAPY AGENTS IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - AN UPDATE INCLUDING DATA FROM THE 7TH WORLD CONFERENCE ON LUNG-CANCER
Authors: COMIS RL FRIEDLAND DM
Citation: Rl. Comis et Dm. Friedland, NEW CHEMOTHERAPY AGENTS IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - AN UPDATE INCLUDING DATA FROM THE 7TH WORLD CONFERENCE ON LUNG-CANCER, Lung cancer, 12, 1995, pp. 63-99
PERIOPERATIVE THERAPY OF NON-SMALL-CELL LUNG-CANCER - A REVIEW OF ADJUVANT AND NEOADJUVANT APPROACHES
Authors: FRIEDLAND DM COMIS RL
Citation: Dm. Friedland et Rl. Comis, PERIOPERATIVE THERAPY OF NON-SMALL-CELL LUNG-CANCER - A REVIEW OF ADJUVANT AND NEOADJUVANT APPROACHES, Seminars in oncology, 22(6), 1995, pp. 571-581
PACLITAXEL BY 24- OR 1-HOUR INFUSION IN COMBINATION WITH CARBOPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - THE FOX CHASE CANCER CENTER EXPERIENCE
Authors: LANGER CJ LEIGHTON JC COMIS RL ODWYER PJ MCALEER CA BONJO CA ENGSTROM PF LITWIN S JOHNSON S OZOLS RF
Citation: Cj. Langer et al., PACLITAXEL BY 24- OR 1-HOUR INFUSION IN COMBINATION WITH CARBOPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - THE FOX CHASE CANCER CENTER EXPERIENCE, Seminars in oncology, 22(4), 1995, pp. 18-29
CONSTRUCTION OF HUMAN CHROMOSOME-3-SPECIFIC RADIATION HYBRIDS AND CHARACTERIZATION BY ALU-PCR
Authors: ATCHISON L COMIS RL ATCHISON ML
Citation: L. Atchison et al., CONSTRUCTION OF HUMAN CHROMOSOME-3-SPECIFIC RADIATION HYBRIDS AND CHARACTERIZATION BY ALU-PCR, Gene, 151(1-2), 1994, pp. 321-324
CONSTRUCTION OF RARE RESTRICTION SITE (NOTI, SACII AND CLAI) LINKING LIBRARIES AND SEQUENCE-TAGGED SITE ANALYSIS OF SINGLE-COPY CLONES FROMA HUMAN CHROMOSOME-3-SPECIFIC LIBRARY
Authors: ATCHISON L COMIS RL ATCHISON ML
Citation: L. Atchison et al., CONSTRUCTION OF RARE RESTRICTION SITE (NOTI, SACII AND CLAI) LINKING LIBRARIES AND SEQUENCE-TAGGED SITE ANALYSIS OF SINGLE-COPY CLONES FROMA HUMAN CHROMOSOME-3-SPECIFIC LIBRARY, Gene, 151(1-2), 1994, pp. 325-328
CISPLATIN - THE FUTURE
Authors: COMIS RL
Citation: Rl. Comis, CISPLATIN - THE FUTURE, Seminars in oncology, 21(5), 1994, pp. 109-113
PHARMACOKINETICS AND BIOAVAILABILITY STUDY OF ETHACRYNIC-ACID AS A MODULATOR OF DRUG-RESISTANCE IN PATIENTS WITH CANCER
Authors: LACRETA FP BRENNAN JM NASH SL COMIS RL TEW KD ODWYER PJ
Citation: Fp. Lacreta et al., PHARMACOKINETICS AND BIOAVAILABILITY STUDY OF ETHACRYNIC-ACID AS A MODULATOR OF DRUG-RESISTANCE IN PATIENTS WITH CANCER, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1186-1191
ANALYSIS OF CLINICAL-TRIALS EMPLOYING PREOPERATIVE CHEMOTHERAPY AND OR THORACIC RADIATION-THERAPY (TRT) FOR MARGINALLY RESECTABLE NONSMALL CELL LUNG-CANCER/
Authors: CURRAN WJ LANGER CJ KELLER SM COMIS RL
Citation: Wj. Curran et al., ANALYSIS OF CLINICAL-TRIALS EMPLOYING PREOPERATIVE CHEMOTHERAPY AND OR THORACIC RADIATION-THERAPY (TRT) FOR MARGINALLY RESECTABLE NONSMALL CELL LUNG-CANCER/, International journal of radiation oncology, biology, physics, 27, 1993, pp. 189-189
INTRAPERITONEAL CISPLATIN AND ETOPOSIDE IN PERITONEAL MESOTHELIOMA - FAVORABLE OUTCOME WITH A MULTIMODALITY APPROACH
Authors: LANGER CJ ROSENBLUM N HOGAN M NASH S BAGCHI P LACRETA FP CATALANO R COMIS RL ODWYER PJ
Citation: Cj. Langer et al., INTRAPERITONEAL CISPLATIN AND ETOPOSIDE IN PERITONEAL MESOTHELIOMA - FAVORABLE OUTCOME WITH A MULTIMODALITY APPROACH, Cancer chemotherapy and pharmacology, 32(3), 1993, pp. 204-208
CARBOPLATIN IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - A REVIEW
Authors: COMIS RL
Citation: Rl. Comis, CARBOPLATIN IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - A REVIEW, Oncology, 50, 1993, pp. 37-41
PHASE-I PHARMACOKINETIC BIOCHEMICAL-STUDY OF THE NITROIMADAZOLE HYPOXIC CELL SENSITIZER SR2508 (ETANIDAZOLE) IN COMBINATION WITH CYCLOPHOSPHAMIDE
Authors: ODWYER PJ LACRETA FP WALCZAK J COX T LITWIN S HOFFMAN JP ZIMNY M COMIS RL
Citation: Pj. Odwyer et al., PHASE-I PHARMACOKINETIC BIOCHEMICAL-STUDY OF THE NITROIMADAZOLE HYPOXIC CELL SENSITIZER SR2508 (ETANIDAZOLE) IN COMBINATION WITH CYCLOPHOSPHAMIDE, British Journal of Cancer, 68(4), 1993, pp. 756-766
Risultati: 1-23 |